Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion
  2. Rawat, S. S.; Viard, M.; Gallo, S. A.; Blumenthal, R.; Puri, A.
  3. Glycoconjugate Journal. 2006, MAY; 23(3-4): 189-197.
  1. 2.   CB694, a novel antimitotic with antitumor activities
  2. Weiderhold, K. N.; Randall-Hiubek, D. A.; Polin, L. A.; Hamel, E.; Mooberry, S. L
  3. International Journal of Cancer. 2006, FEB 15; 118(4): 1032-1040.
  1. 3.   TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling
  2. Kim, Y. S.; Nedospasov, S. A.; Liu, Z. G.
  3. Molecular and Cellular Biology. 2005, MAR; 25(6): 2130-2137.
  1. 4.   Dynamic fluorescent imaging of human immunodeficiency virus type 1 Gag in live cells by biarsenical labeling
  2. Rudner, L.; Nydegger, S.; Coren, L. V.; Nagashima, K.; Thali, M.; Ott, D. E.
  3. Journal of Virology. 2005 79(7): 4055-4065.
  1. 5.   Novel protein-protein interactions of the Yersinia pestis type III secretion system elucidated with a matrix analysis by surface plasmon resonance and mass spectrometry
  2. Swietnicki, W.; O'Brien, S.; Holman, K.; Cherry, S.; Brueggemann, E.; Tropea, J. E.; Hines, H. B.; Waugh, D. S.; Ulrich, R. G.
  3. Journal of Biological Chemistry. 2004, SEP 10; 279(37): 38693-38700.
  1. 6.   O-6-benzylguanine-mediated enhancement of chemotherapy
  2. Friedman, H. S.; Keir, S.; Pegg, A. E.; Houghton, P. J.; Colvin, O. M.; Moschel, R. C.; Bigner, D. D.; Dolan, M. E.
  3. Molecular Cancer Therapeutics. 2002 1(11): 943-948.
  1. 7.   Phase II trial of carmustine plus O-6-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma
  2. Quinn, J. A.; Pluda, J.; Dolan, M. E.; Delaney, S.; Kaplan, R.; Rich, J. N.; Friedman, A. H.; Reardon, D. A.; Sampson, J. H.; Colvin, O. M.; Haglund, M. M.; Pegg, A. E.; Moschel, R. C.; McLendon, R. E.; Provenzale, J. M.; Gururangan, S.; Tourt-Uhlig, S.; Herndon, J. E.; Bigner, D. D.; Friedman, H. S.
  3. Journal of Clinical Oncology. 2002 20(9): 2277-2283.
  1. 8.   The role of NF-kappa B in the regulation of cell stress responses
  2. Wang, T. L.; Zhang, X.; Li, J. J.
  3. International Immunopharmacology. 2002 2(11): 1509-1520.
  1. 9.   Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation
  2. Li, Z. K.; Xia, L. Q.; Lee, L. M.; Khaletskiy, A.; Wang, J. Y.; Wong, J. Y. C.; Li, J. J.
  3. Radiation Research. 2001 155(4): 543-553.
  1. 10.   Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma
  2. Friedman, H. S.; Pluda, J.; Quinn, J. A.; Ewesuedo, R. B.; Long, L.; Friedman, A. H.; Cokgor, I.; Colvin, O. M.; Haglund, M. M.; Ashley, D. M.; Rich, J. N.; Sampson, J.; Pegg, A. E.; Moschel, R. C.; McLendon, R. E.; Provenzale, J. M.; Stewart, E. S.; Tourt-Uhlig, S.; Garcia-Turner, A. M.; Herndon, J. E.; Bigner, D. D.; Dolan, M. E.
  3. Journal of Clinical Oncology. 2000 18(20): 3522-3528.
  1. 11.   Enhanced Levels of Staphylococcus Aureus Stress Protein Groel and Dnak Homologs Early in Infection of Human Epithelial Cells
  2. Qoronfleh, M. W.; Bortner, C. A.; Schwartzberg, P.; Wilkinson, B. J.
  3. Infection and Immunity. 1998 66(6): 3024-3027.
  1. 12.   Phase I Trial of O-6-Benzylguanine For Patients Undergoing Surgery For Malignant Glioma
  2. Friedman, H. S.; Kokkinakis, D. M.; Pluda, J.; Friedman, A. H.; Cokgor, I.; Haglund, M. M.; Ashley, D. M.; Rich, J.; Dolan, M. E.; Pegg, A. E.; Moschel, R. C.; McLendon, R. E.; Kerby, T.; Herndon, J. E.; Bigner, D. D.; Schold, S. C.
  3. Journal of Clinical Oncology. 1998 16(11): 3570-3575.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel